MSCs use CCL2 for the recruitment and subsequent contact-dependent inhibition of inflammatory Th17 cells and for the homing of Tregs and myeloid-derived suppressor cells to the damaged organs in models of experimental autoimmune encephalomyelitis and experimental autoimmune uveitis 61, 62. This evidence concerns the gene CCL2 and experimental autoimmune encephalomyelitis.